Determining the origin of lethal metastases in multifocal primary prostate cancer [ 2013 - 2016 ]

Research Grant

Researchers: Prof Christopher Hovens (Principal investigator) ,  A/Pr Andrew Lonie ,  A/Pr Izhak Haviv ,  A/Pr John Pedersen ,  Dr Adam Kowalczyk
View all 9 related researchers

Brief description New biomarkers are required to accurately predict lethal prostate cancer from benign, indolent disaese that doesn't require expensive treatment. To do this relies on finding molecular differences between disease states. Advancements in high throughput genomic technologies enables us to now probe the lethal prostate cancer genome and transcriptome and distinguish this disease state from other forms of prostate cancer.

Funding Amount $AUD 696,470.89

Funding Scheme Project Grants

Notes Standard Project Grant